Biggest News Aggregation in the World
📰 Jefferies Llc News

Jefferies Llc News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Jefferies Llc. Real-time updates on events, politics, business and more.

Modi enjoys a $3.8 trillion market moment as G-20 leaders fly in

Indias stock market hit an all-time high valuation of $3.8 trillion this week, a perfectly timed billboard for Modi as the G-20 summit gives him another opportunity to showcase the nations potential as a geopolitical juggernaut. With the West looking to curb Chinas influence, Modi has rolled out a mix of tariffs and incentives to lure companies to make in India and firms including Apple Inc. and Samsung Electronics Co. are among those expanding production in the nation.
New Delhi City Of United Kingdom Narendra Modi Chris Wood Peter Marber

Bullish annonce son intention d'entrée à la Bourse de New York

ITespresso.fr BusinessWire, Bullish, une tech spécialisée dans le développement de services financiers pour le secteur des actifs numériques, a annoncé son intention d’entrer à la Bourse de New York par le biais d’une fusion avec Far Peak Acquisition Corporation (NYSE: FPAC), une société d’acquisition à vocation spécifique (« SAVS »). Bullish s’apprête à lancer une plateforme de cryptodevises révolutionnaire et réglementée offrant de vastes li...
New York United States Brendan Blumer Alan Howard Exchange Commission American Jefferies Llc

Aclaris Announces Pricing of Public Offering of Common Stock

WAYNE, Pa., June 09, 2021 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (Nasdaq:ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced the pricing of its underwritten public offering of 7,042,254 shares of its common stock at a price to the public of $17.75 per share. In addition, Aclaris has granted to the underwriters a 30-day option to purchase up to 1,056,338 additional shares of common stock at the pub
Aclaris Therapeutics Iopharmaceutical Company Public Offering Prospectus Department Prospectus Supplement Jefferies Llc
Source: yahoo.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

ASLAN Pharmaceuticals Announces Pricing of Public Offering of American Depositary Shares

SINGAPORE, March 03, 2021 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced the pricing of an underwritten public offering of 15,000,000 American Depositary Shares (“ADSs”) representing 75,000,000 ordinary shares at a price to the public of $4.00 per ADS. The gross proceeds from this offering are expected to be $60.0 million, bef...
Prospectus Department Biopharmaceutical Company Prospectus Supplement Jefferies Llc ப்ரோஸ்பெக்டஸ் துறை ப்ரோஸ்பெக்டஸ் துணை
Source: yahoo.com

Cerecor Inc. Announces Pricing of $36.4 Million Public Offering of Common Stock and Pre-Funded Warrants

ROCKVILLE, Md. and CHESTERBROOK, Pa., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Cerecor Inc. (Nasdaq: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare pediatric and orphan diseases, announced today that it has entered into an underwriting agreement with Jefferies LLC under which the underwriters agreed to purchase, on a firm commitment basis, 12,323,077 shares of common stock of the Company, at a public offering price of $2.60 pe...
Cerecor Inc Biopharmaceutical Company Clinical Development Common Stock Orphan Diseases Jefferies Llc
Source: yahoo.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science